ストックスクリーナーアプリを入手
1.03
0.96%
-0.01
アフターアワーズ：
1.03
前日終値:
$1.04
開ける：
$1.01
24時間の取引高:
56,878
Relative Volume:
0.22
時価総額：
$56.60M
収益：
$33.79M
当期純損益:
$-18.67M
株価収益率:
-2.8755
EPS:
-0.3582
ネットキャッシュフロー:
$-19.17M
1週間 パフォーマンス:
+9.84%
1か月 パフォーマンス:
+27.14%
6か月 パフォーマンス:
-6.36%
1年 パフォーマンス:
+1.98%
1日の値動き範囲:
$1.01
$1.0396
1週間の範囲:
$0.92
$1.1418
52週間の値動き範囲:
$0.70
$1.59
Cytosorbents Corp Stock (CTSO) Company Profile
CTSO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
1.03 | 56.60M | 33.79M | -18.67M | -19.17M | -0.3582 |
|
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-09-07 | 開始されました | B. Riley Securities | Buy |
| 2021-10-14 | 再開されました | B. Riley Securities | Buy |
| 2020-09-17 | 開始されました | Jefferies | Buy |
| 2020-09-01 | 開始されました | SVB Leerink | Outperform |
| 2017-08-08 | 繰り返されました | Maxim Group | Buy |
| 2016-10-26 | 開始されました | Aegis Capital | Buy |
| 2016-05-24 | 開始されました | Maxim Group | Buy |
| 2015-10-29 | アップグレード | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | 繰り返されました | MLV & Co | Buy |
| 2015-04-01 | 繰り返されました | MLV & Co | Buy |
| 2015-03-05 | 開始されました | MLV & Co | Buy |
| 2015-02-25 | 開始されました | WBB Securities | Speculative Buy |
| 2015-01-27 | 繰り返されました | H.C. Wainwright | Buy |
すべてを表示
Cytosorbents Corp (CTSO) 最新ニュース
CytoSorbents Strengthens Balance Sheet with Successful Conclusion of Rights Offering - Defense World
Cytosorbents Boosts Liquidity with Successful Rights Offering - Yahoo Finance
Cytosorbents (NASDAQ:CTSO) Given Buy Rating at D. Boral Capital - Defense World
D. Boral Capital Reiterates Buy Rating for Cytosorbents (NASDAQ:CTSO) - MarketBeat
Expert Outlook: CytoSorbents Through The Eyes Of 7 Analysts - Benzinga
CytoSorbents closes oversubscribed rights offering - TipRanks
CytoSorbents Raises $6.25M in Oversubscribed Rights Offering, Unlocks $5M Restricted Cash - StockTitan
Cytosorbents (NASDAQ:CTSO) Now Covered by StockNews.com - Defense World
Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com - MarketBeat
Cytosorbents Co. (NASDAQ:CTSO) Stake Boosted by Geode Capital Management LLC - Defense World
Skylands Capital, LLC Increases Stake in CytoSorbents Corp - GuruFocus.com
Revenue Surge & Breakthrough Margins Fuel Growth in Critical Care Tech - Streetwise Reports
CytoSorbents opens new sales subsidiary in Dubai - Investing.com
CytoSorbents Expands Global Reach with Strategic Dubai Hub for Middle East & Africa Growth - StockTitan
Cytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.com - Defense World
CytoSorbents reported strong Q4 results, says D. Boral Capital - Yahoo Finance
Health Care Equipment Supplier CytoSorbents Shares Dip Despite Projected Revenue Growth - Benzinga
Cytosorbents' (CTSO) Buy Rating Reiterated at D. Boral Capital - MarketBeat
CytoSorbents reports revenue growth in Q4 - Investing.com
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue - Quantisnow
StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - MarketBeat
Cytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.com - Defense World
Comparing Cytosorbents (NASDAQ:CTSO) & Presbia (OTCMKTS:LENSF) - Defense World
CytoSorbents begins rights offering for stockholders - Investing.com
CytoSorbents Launches $1.00 Rights Offering with Discounted Warrant Package for Shareholders - StockTitan
CytoSorbents Rights Offering Begins - GlobeNewswire
StockNews.com Begins Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World
Peter J. Mariani Purchases 20,000 Shares of Cytosorbents Co. (NASDAQ:CTSO) Stock - MarketBeat
Cytosorbents CFO Peter J. Mariani buys $19,294 in common stock - Investing.com India
Cytosorbents CFO Peter J. Mariani buys $19,294 in common stock By Investing.com - Investing.com Nigeria
Cytosorbents Co. (NASDAQ:CTSO) Short Interest Update - MarketBeat
Cytosorbents CFO Peter Mariani buys $27,974 in stock - Investing.com
KORU Medical Systems (NASDAQ:KRMD) and Cytosorbents (NASDAQ:CTSO) Head-To-Head Comparison - Defense World
CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week - Yahoo Finance
CytoSorbents Announces Commencement of Shareholder Rights Warrant Offering - Defense World
CTSOCytosorbents Corp. Latest Stock News & Market Updates - StockTitan
CytoSorbents sets terms for anticipated Rights Offering - Investing.com
SEC Form FWP filed by Cytosorbents Corporation - Quantisnow
CytoSorbents Announces Rights Offering - Quantisnow
CTSO (CytoSorbents) 3-Year Revenue Growth Rate : -11.80% (As of Sep. 2024) - GuruFocus.com
CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference - StockTitan
Cytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.com - Defense World
Granahan Investment Management Reduces Stake in CytoSorbents Cor - GuruFocus.com
FY2024 EPS Estimates for Cytosorbents Decreased by Analyst - Defense World
FY2024 EPS Estimate for Cytosorbents Decreased by Analyst - MarketBeat
Several Insiders Invested In Cytosorbents Flagging Positive News - Yahoo Finance
Cytosorbents Corporation (NASDAQ:CTSO) Q3 2024 Earnings Call Transcript - Insider Monkey
CytoSorbents And Converge Biotech Announce Strategic - GlobeNewswire
CytoSorbents Expands Into India Through Strategic Converge Biotech Partnership | CTSO Stock News - StockTitan
CytoSorbents Corp (CTSO) Q3 2024 Earnings Call Highlights: Stron - GuruFocus.com
Cytosorbents Corp (CTSO) 財務データ
収益
当期純利益
現金流量
EPS
0.25%
0.57%
大文字化:
|
ボリューム (24 時間):